GastroIntestinal / Gastroentorology News From Medical News Today
Latest GastroIntestinal / Gastroenterology News From Medical News Today.
- Last build:
- Language:
- en-us
- Feed URL:
- http://www.medicalnewstoday.com/rss/gastrointestinal.xml
RSS FEED IDEMS: GastroIntestinal / Gastroentorology News From Medical News Today
- Useful And Effective Diagnosis Of Patients With Large Bowel Obstruction Using CT
The use of CT is highly effective in confirming large bowel obstruction and identifying the site and cause of obstruction, according to a recent study conducted by researchers at the University of South Manchester in Manchester, UK."There is very little published evidence regarding the diagnostic efficiency of CT in large bowel obstruction (LBO), said Sathi Sukumar, MD, lead author of the study.
Mon, 14 Apr 2008 03:00:00 PDT - Covidien Unveils The Next Generation In Advanced Surgery
Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that its Energy-based Devices business unit has introduced LigaSure Advance™, the first multifunctional laparoscopic instrument that offers surgeons fingertip control of both tissue fusion and monopolar dissection. LigaSure Advance™ was created in response to what surgeons said they need to optimize efficiency and safety in the operating room.
Mon, 14 Apr 2008 01:00:00 PDT - Removal Of Superficial Tumours In Oesophagus By Endoscopy Can Avoid Complete Extirpation Of This Part Of The Digestive Tract
The removal through endoscopy of tumours that affect only the superficial layers of the oesophagus can avoid complete extirpation of this part of the digestive tract. The technique, carried out at the University Hospital of Navarra for the last three years, was presented at the VI International Course on Therapeutic Endoscopy in the Digestive System, organized by the Digestive System Service at this hospital.
Sun, 13 Apr 2008 04:00:00 PDT - New Procedure In Diagnosing Small Bowel Disorders Proves Efficient And Effective
Sonoenteroclysis, a new sonographic method in evaluating and diagnosing small bowel disorders is an effective alternative to the usual method of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. Sonoenteroclysis is a new way of doing transabdominal ultrasound. Patients are given fluid through the nasojejunal tube in order to alleviate gas in the bowel.
Sat, 12 Apr 2008 00:00:00 PDT - New Pan-European Collaboration Launched Into The Diagnosis And Control Of Coeliac Disease
12 million euros, equivalent to nearly 9.5 million pounds has been invested by the European Commission into a new pan-European partnership which will design an advanced diagnostic tool for the detection and control of coeliac disease, the most under-diagnosed common chronic condition in the UK today.
Fri, 11 Apr 2008 05:00:00 PDT - Cancer Pathways That Also Control The Adult Stem Cell Population
Speaking at the UK National Stem Cell Network Annual Science Meeting in Edinburgh, Professor Alan Clarke from Cardiff University described his work to investigate a mechanism that normally drives adult stem cells to repair the intestine.
Fri, 11 Apr 2008 02:00:00 PDT - Napo Announces Successful Clinical Results In Phase 2 Study Of Crofelemer In Acute Adult Infectious Diarrhea
Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark).
Fri, 11 Apr 2008 00:00:00 PDT - For Crohn's Patients, Omega-3 Fatty Acids Not Effective In Preventing Relapse
Administrationof omega-3 fatty acid supplements did not appear to improve the rate ofrelapse in patients with Crohn's disease, according to a study releasedon April 9, 2008 in JAMA. Crohn'sDisease is a gastrointestinal disorder which is indicated bychronicinflammation of the wall of the digestive tract, usually in the ileumor large intestines.
Tue, 08 Apr 2008 13:00:00 PDT - Anti-Cancer Activity Of Tea In Gastrointestinal Cells Affected By Digestive Process
Increased consumption of teas rich in catechins is associated with reduced risk of stomach, colon and other gastrointestinal cancers. However, the effects of digestion on the anticancer activity of tea catechins have largely been ignored. A study by nutrition researchers at The Ohio State University and Purdue University found that the digestive process could both alter the structure of the tea catechins and their anticancer activity.
Tue, 08 Apr 2008 04:00:00 PDT - The GI Company To Present Phase I & II Oral Mucositis Data At MASCC / ISOO Annual Meeting
The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, announced that an abstract detailing combined results from its Phase I and Phase II clinical trials has been accepted for a poster presentation at the Multinational Association of Supportive Care in Cancer's and the International Society of Oral Oncology's 2008 International Symposium on Supportive Care in Cancer (MASCC / ISOO). The symposium takes place June 26-28, 2008 at the Hilton Hotel Houston, Texas.
Tue, 08 Apr 2008 04:00:00 PDT - Recombinant Human Intestinal Trefoil Factor (rhITF) Oral Spray For Prophylaxis Of Chemotherapy-induced Oral Mucositis
The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, announced that an abstract detailing combined results from its Phase I and Phase II clinical trials has been accepted for a poster presentation at the Multinational Association of Supportive Care in Cancer's and the International Society of Oral Oncology's 2008 International Symposium on Supportive Care in Cancer (MASCC / ISOO). The symposium takes place June 26-28, 2008 at the Hilton Hotel Houston, Texas.
Tue, 08 Apr 2008 01:00:00 PDT - FDA Approves ROTARIX(R) Rotavirus Vaccine
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants. With only two doses, ROTARIX will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age. The U.S.
Mon, 07 Apr 2008 03:00:00 PDT - FDA Approves Rotarix [Rotavirus Vaccine, Live, Oral], The First Vaccine Licensed To Complete The Rotavirus Immunisation Series By Four Months Of Age
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. Rotarix will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age. The U.S.
Sun, 06 Apr 2008 00:00:00 PDT - FDA Approves New Vaccine To Prevent Gastroenteritis Caused By Rotavirus
The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 weeks of age. Although the disease is usually self-limiting, rotavirus causes about 2.7 million cases of gastroenteritis in U.S.
Fri, 04 Apr 2008 05:00:00 PDT - SAGES/ACS Fundamentals Of Laparoscopic Surgery (FLS) Program Receives Landmark Grant From Covidien
The Fundamentals of Laparoscopic Surgery (FLS), a joint educational program from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American College of Surgeons (ACS), has received a $1.8 million grant from Covidien, a leading manufacturer of medical devices and supplies, to launch The Covidien Educational Fund.
Fri, 04 Apr 2008 01:00:00 PDT
